Lindis Blood Care Announces Successful Financing for its Tumor-Cell-Removal Medical Device, CATUVAB®
First closing of funding round supported by Brandenburg Kapital, High-Tech Gründerfonds, existing and new private investors; second closing expected by the end of Q1 2025
Funds to be used in preparing for upcoming approval and product launch of…